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TCT-334
Equivalent Improvement Of Cardiac Function After Delayed Reperfusion By
Primary Percutaneous Coronary Intervention for ST-Segment Elevation
Myocardial Infarction
Shinichiro Yamada, Hiroyuki Shibata, Takatoshi Hayashi, Yasuyo Taniguchi,
Takayoshi Toba, Tomofumi Takaya, Naoki Miyoshi, Katsunori Okajima, Akira
Shimane, Seiichi Kobayashi, Kiminobu Yokoi, Gaku Kanda, Shougo Oishi, Mitsuhiro
Yokoyama
Himeji Cardiovascular Center, Himeji, Japan
Background: Efficacy of primary percutaneous intervention (pPCI) for ST-segment
elevation myocardial infarction (STEMI) within 6 hours after the symptom onset has
been established, however, whether the equivalent efficacy is obtained in ‘delayed’
pPCI is still controversial.
Methods: We investigated 374 patients with STEMI who had undergone pPCI within
24 hours after symptom onset. They were divided into two groups: pPCI within 6 hours
(Early group) and pPCI between 6-24 hours (Delayed group) after onset. Those with
TIMI grade 3 at the time of diagnostic coronary angiography were excluded. ECG-
gated 99m-Tc-Tetrofosmin (TcTF) and 123-I-BMIPP SPECT were performed between
7-10 days (Acute phase) and TcTF was repeated 3 months (Chronic phase) after onset.
Myocardium was divided into 25 segments and segmental score was graded by 5
degrees (0:normal, 4:defect). Sum of defect scores (S-DS) were calculated from
SPECT, and ejection fraction (LVEF) / left ventricular volume from QGS software.
Results: There were no significant differences of final TIMI grade or prevalence of
ST resolution between two groups. Baseline myocardial perfusion and LVEF evaluated
by TcTF, fatty acid metabolism by BMIPP at acute phase were not different
significantly between two groups. In both early and late group, improvement of
myocardial perfusion defect and LVEF were observed.
Conclusion: Primary PCI for STEMI provides the improvement of cardiac function
including perfusion, metabolism and LV function even when performed beyond 6 hours
after the onset.
TCT-335
Clinical Outcomes Of Primary Percutaneous Coronary Intervention In Elderly
Versus Younger Patients Presenting with Acute Myocardial Infarction (From
the KAMIR)
Jin Hee Choi, Jun Hyok Oh, Hye Won Lee, Bo Won Kim, Sung Gyu An, Mi Jin Yang,
Junghyun Choi, Han Cheol Lee, Kwang Soo Cha, Taek Jong Hong
Pusan National University Hospital, Busan, Republic of Korea
Background: Elderly patients have been either excluded or underrepresented in acute
myocardial infarction (AMI) clinical trials. To understand the impact of age on
treatment, outcomes and complications, we analyzed the largest group of patients 75
years or older with AMI from registry.
Methods: We analyzed data from 14885 patients in the Korea Acute Myocardial
Infarction Registry(KAMIR) between October 2005 and June 2008. Patients were
divided into two groups: those ≥ 75years(n=2915) and those < 75years(n=11970). The
main clinical outcomes were 1-year major adverse cardiovascular events(MACE) and
bleeding after primary percutaneous coronary intervention(PPCI).
Results: Elderly patients had higher rates of hypertension, diabetes and previous
ischemic heart disease and less angiographic success after PPCI. There were less use
of short-term adjunctive and antiplatelet medications in elderly compared with younger
patients. However, major bleeding rate was higher in the elderly group(0.4% vs. 0.8%,
p=0.01). In elderly patents, 1-year MACE(1.5% vs. 7.5%, p<0.001) and mortality
rate(4.4% vs. 10.2%, p<0.001) were found to be higher. After multivariable adjustment,
age was the strongest independent predictor of 1-year MACE (odds ratio[OR]=1.753,
95% confidence interval[CI]=1.316-2.333, p<0.001) and 1-year mortality(OR=4.844,
95% CI=3.551-6.608, p<0.001).
The Main Clinical Outcomes
Conclusion: Elderly patients had less use of antiplatelet medications and higher rates
of major bleeding, 1-year MACE and mortality. Age with 75 years or older is the
strongest predictor of 1-year MACE and mortality in AMI patients undergoing PPCI
in this analysis. Therefore, a thorough understanding of the prognosis and a cautious
approach in management of the elderly patients with AMI are needed.
TCT-336
Patient Differences by Mode of Hospital Arrival for ST-Elevation Myocardial
Infarction Treated with Primary PCI
Robert S Lee, Rishi Kaushal, Tasneem Bholat, Katrine A Zhiroff, Sandra C Jaquez,
Quang T Bui, Joseph L Thomas, William J French
Cardiology, Harbor UCLA Medical Center, Torrance, CA
Background: Outcomes for STEMI treated with primary PCI are improved by
initiatives including pre-hospital ECG and paramedic transfer to STEMI receiving
centers (SRC). STEMI patients self-presenting to a regional SRC have not been well-
studied and may not have the same characteristics or outcomes.
Methods: The records for all acute STEMI patients undergoing primary PCI between
May 2007 and December 2010 at an urban SRC were reviewed. Continuous and
categorical variables were analyzed with standard tools.
Results: Patients who “walk-in” to a regional SRC with STEMI are significantly
different from those presenting via emergency medical services with field ECGs. Non-
English speaking and some minority groups are more likely to present as “walk-in”
STEMIs. Patients with inferior MI, advanced Killip Class and history of MI, PCI or
CVA are more likely to present via paramedics.
Patient Differences at Presentation
Conclusion: Marked clinical and demographic differences exist between SRC and
“walk-in” patients with STEMI. Further study and improved public health education
are needed to address these differences.
TCT-337
Does the Increase in Mortality in Patients with Acute Myocardial Infarction
Admitted on Weekends Still Exist?
Abhishek Deshmukh1, 2, Gagan Kumar1, Sandeep Singla1, Freij Gobal1, Shailesh
Fnu1, Rajesh Sachdeva1, 2, Jawahar L Mehta1, 2
1University of Arkansas, Little Rock, AR; 2Central Arkansas Veterans Healthcare
System, Little Rock, AR
Background: Prior studies have suggested worse outcomes for acute myocardial
infarction(AMI) hospitalizations on weekends.Improvement in system based practices
and refined care has lead to better outcomes.There are no data on trends in outcomes
of AMI patients hospitalized on weekends in recent years.
Methods: This was a cross sectional study using the Nationwide Inpatient Sample
from the years 2000 to 2008.5,848,502 discharges with AMI and its related
revascularization procedures were identified through appropriate ICD 9 codes.Weekend
admissions were defined as all admissions between midnight Friday through midnight
Sunday.The primary outcome measured was in-hospital mortality.
Results: Of the 5,848,502 hospitalizations of AMI,25.3% were admitted on a
weekend.Overall,patients admitted on a weekend had significantly increased
mortality(6.66% vs. 6.13%, p<0.05.Mortality trends of weekend admissions from years
2000-2008 are shown in Fig 1.Mortality of AMI patients admitted on weekends in the
year 2000 was significantly higher compared to weekday admissions (adjusted HR
1.09, 95CI 1.04-1.14,p<0.001).In 2008,there was no significant difference in mortality
in patients admitted on a weekend vs. those admitted on a weekday (adjusted HR 1.03,
95% CI 0.97-1.10, p=0.22).The number of cardaic catheterization procedures
performed within 24 hours on weekends increased from 36.2% in 2000 to 54.5% in
2008 (p< 0.001),while on weekdays it increased from 53.6% in 2000 to 65% in 2008.
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Fig 1
Conclusion: This study confirms higher mortality of AMI patients admitted on
weekends in the beginning of the decade;The difference in mortality of AMI is not
observed in recent years reflecting improved care.
TCT-338
Associations between symptom-to-door time and biomarkers on 12-month
mortality in patients with acute myocardial infarction
Jang Hoon Lee, Kyun Hee Kim, Won Suk Choi, Sun Hee Park, Dong Heon Yang,
Hun Sik Park, Yongkeun Cho, Shung Chull Chae, Jae Eun Jun
Kyungpook National University Hospital, Daegu, Republic of Korea
Background: Little is known about the associations between symptom-to-door (STD)
time and biomarkers including N-terminal pro-B type natriuretic peptide (NT-proBNP)
and high sensitivity C-reactive protein (hs-CRP) in patients with acute myocardial
infarction (AMI).
Methods: Between November 2005 and February 2010, 1,233 patients were followed
up more than 12-month after their AMI and finally analyzed in this study. The patients
who had STD time more than 3 days were excluded from this study. Patients were
categorized into 3 groups based on their STD time; Group I (STD time < 6-hour,
n=767), Group II (6-hour ≤ STD time ≤ 12-hour, n=181), and Group III (STD time >
12-hour, n=285).
Results: The 12-month mortality was significantly higher in Group III (13.7%)
compared to Group I (9.3%) and Group II (11.0%)(p for trend = 0.037). The serum
levels of log-transformed NT-proBNP were significantly higher in Group III (7.48±1.70
pg/mL) compared to Group I (5.77±2.06 pg/mL) and Group II (6.64±1.73 pg/mL)(p
for trend<0.001). The serum levels of log-transformed hs-CRP were also significantly
higher in Group III (1.72±1.74 mg/L) compared to Group I (0.87±1.55 mg/L) and
Group II (1.21±1.69 mg/L)(p for trend<0.001). The patients with symptomatic heart
failure at admission (Killip class >2) were significantly higher in Group III (p=0.041),
and left ventricular ejection fraction was significantly higher in Group I (p=0.006). In
Cox proportional hazards model, Group III (crude hazard ratio [HR] 1.516, 95%
confidence interval [CI] 1.026-2.241, p =0.037) had significantly higher 12-month
mortality compared with Group I. In Group III, elevated serum levels of log-
transformed NT-pro BNP (HR 2.761, 95% CI 1.084-7.036, p =0.033), not
log-transformed hs-CRP, in addition to age (HR 1.114, 95% CI 1.025-1.210, p =0.011)
and body mass index (HR 1.423, 95% CI 1.087-1.864, p =0.010) were independent
predictors of 12-month mortality after adjustment for confounding variables.
Conclusion: The STD time is significantly associated with the serum levels of NT-
proBNP and hs-CRP, and NT-proBNP is independent predictor of 12-month mortality,
particularly in patients with longer STD time.
TCT-339
Transradial Intervention Procedure for Un-Shock, ST Segment Elevation
Myocardial Infarction Patients with Palpable Radial Artery
Hung Minh Ngo, Nhan T Vo
Interventional Cardiology, Choray Hospital, Ho Chi Minh City, Viet Nam
Background: Primary Percutaneous Coronary Intervention (PPCI) which is most
performed via Trans-Femoral Intervention Procedure (TFIP) is currently a standard of
care. Trans-Radial Intervention Procedure (TRIP) has been emerging around the world
as an alternative approach in both elective and primary angioplasty. We examine
whether TRIP which provides efficacy, less bleeding and more comfortable for patient
is as feasible as the standard TFIP.
Methods: A total of 524 consecutive patients who underwent PPCI for STEMI from
1/2009 to 12/2010 were enrolled into cross-sectional study. Patients who were un-
shock and had palpable radial pulses were randomly assigned to receive TRIP and TFIP
for primary angioplasty. The study endpoints were partial and total procedure,
fluoroscopy time (minute), and amount of contrast media (ml).
Results: There were 249 and 275 patients in TRIP and TFIP groups respectively. All
patients were pretreated with dual antiplatelet therapy and heparin regimen of 60U/kg.
The baseline clinical characteristics was comparable between the 2 groups. Preparation
(9.75±4.33 vs 8.92±4.10; p=0.25), aortic root approach (2.28±2.47 vs 2.12±2.57;
p=0.474), engagement (1.78±1.84 vs 1.56±1.31; p=1.31), revascularization
(15.25±6.90 vs 14.50 ±7.36; p=0.242) time and contrast media (155.64±44.42 vs
153.62±103.62; p=0.79) were comparable between the 2 groups. Puncture time was
in-favor for TRIP (3.06±2.57 vs 2.37±2.45; p=0.003) and as a result, lab door-to-
balloon time in TFIP group was shorter than TRIP group (22.13±8.623 vs 20.21±8.006;
p=0.011). Fluoroscopy time in TRIP group was also longer than TFIP group
(10.08±6.58 vs 8.18±4.24; p=0.001). However, total procedure time was statistically
comparable between the two groups (51.09±15.63 vs 48.50±15.71).
Conclusion: TRIP showed statistically non-inferior to TFIP on almost procedural
parameters during PPCI for un-shock STEMI patients with palpable radial artery.
Although puncture and fluoroscopy time of TRIP remained a short gap to TFIP, TRIP
is really feasible and can be considered as alternative approach in PPCI.
TCT-340
Efficacy and Safety Of The M-Guard Stent In Primary Percutaneous Coronary
Intervention for ST-Elevation Myocardial Infarction
Prodromos Anthopoulos, Ioannis Alexanian, Loukas Pappas, Georgia Karabela,
Josef Moutiris, Costantine Michas, Anastasios Salahas, George Yfantis, Ioannis
Antonellis, Antonios Polydorou
Cath Lab, Evagelismos General Hospital, Athens, Greece
Background: In recent years many strategies have been developed to treat
intracoronary thrombus in STEMI patients undergoing primary PCI. M-Guard(MGS),
is a bare metal stent covered by a thin polymer mesh on its external surface, designed
to trap thrombus between the stent and vessel wall, providing embolic protection. Aim
of this study was to evaluate the effectiveness and safety of MGS at 30 days and 1 year
after pPCI and compare its short term results to a control group from the pre MGS era.
We also examined if the benefit from the use of MGS was independent from the use
of thrombus aspiration(TA) during pPCI.
Methods: 73 consecutive STEMI patients with visible thrombus who underwent pPCI
were enrolled in the study [63.4±13.5 years,men:53]. MGS was successfully placed in
68(93.1%). TA (24/68-35.29%) and balloon predilation (35/68-51.47%) was at the
operators discretion. This group was retrospectively compared with 44 consecutive
STEMI patients who underwent pPCI before the introduction of TA or the MGS. They
served as control group. No differenceses between the 2 groups in baseline
characteristics.
Results: Target vessel revascularization was 0/68 at 30 days and 4/68(5.88%) at 1 year.
Cardiac deaths:0/68 at 30 days and 2/68 at 1 year, both possible stent thrombosis.
TIMI3 was achieved in 62/68(91.17%). Final TIMI was 2.88±0.53 in the MGS group
vs 2.53±0.88 in the control group(p: 0.015). Myocardial Blush Grade(MBG) was
2.36±0.91 vs 1.83±1.21 (p: 0.009) at the end of pPCI respectively. No-reflow
phenomenon occurred in 2/68 patients in the MGS group vs 8/44 in the control
(p:0.008). The subgroup of patients from the MGS group that TA was not performed
were 44 individuals. Final TIMI for them was 2.9±0.3 (p:0.01), compared to the control
group and MBG:2.43±0.88 (p:0.009). No-reflow:0/44,(p:0.006).
Conclusion: -In the setting of pPCI, MGS exhibited low TVR and thrombosis rates at
1 and 12 months, in the high risk group of STEMI patients. -With the use of MGS final
TIMI flow and MBG are higher and the no-reflow incidence lower. -The benefit from
the use of MGS is independent from TA.
TCT-341
Prognostic Consequence of Periprocedural Hemoglobin Decrease with and
without Observed Blood Loss in Patients with ST-elevation Myocardial
Infarction Undergoing Primary Percutaneous Coronary Intervention
Wouter J Kikkert, Sophie H van Nes, Alexander MacLeod Manuel, Krystien Lieve,
Marije Vis, Jan Baan, Karel Koch, Robbert J de Winter, Jan J Piek, Jan G Tijssen,
Jose P Henriques
Academic Medical Center, Amsterdam, Netherlands
Background: Little is known regarding the frequency and sequelae of periprocedural
hemoglobin (Hb) drops with and without observed blood loss in patients undergoing
primary PCI (pPCI) for STEMI. We sought to establish the prognostic value of a
periprocedural Hb decrease with and without observed bleeding.
Methods: We assessed the occurrence of periprocedural hemoglobin decrease with
and without observed blood loss occurring within 10 days from index pPCI, in 1762
consecutive STEMI patients undergoing pPCI between 1-1-2003 and 31-8-2008, in a
large tertiary PCI center. Patients presenting in shock were excluded from our analysis
(final cohort n = 1602). Bleeding and bleeding source were recorded from chart review.
A periprocedural Hb decrease was calculated by subtracting the nadir Hb during index
admission (within 10 days from index procedure) from the baseline Hb. The primary
endpoint was one-year all-cause mortality. The prognostic values of a periprocedural
Hb decrease with and without observed blood loss were calculated using stepwise Cox
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